Publication | Closed Access

Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy

NanomedicineMedicinal ChemistryDrug TargetingEngineeringPolymer-drug ConjugateNano-drug DeliveryTumor TargetingBiomedical EngineeringPharmacologyCarrier-free NanoparticlesProtein Nanoparticles